Anavex Life Sciences
AVXL
#7462
Rank
S$0.55 B
Marketcap
S$6.21
Share price
3.88%
Change (1 day)
-56.62%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -S$61.69 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$66.41 Million a decrease over its 2023 earnings that were of -S$57.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$61.69 Million-7.11%
2024 -S$66.41 Million14.77%
2023 -S$57.87 Million-17.49%
2022 -S$70.13 Million22.96%
2021 -S$57.03 Million35.36%
2020 -S$42.14 Million12.65%
2019 -S$37.4 Million29.09%
2018 -S$28.98 Million36.33%
2017 -S$21.26 Million17.11%
2016 -S$18.15 Million20.91%
2015 -S$15.01 Million-6.29%
2014 -S$16.02 Million337.28%
2013 -S$3.67 Million
2008 -S$6.78 Million106.01%
2007 -S$3.29 Million8848.98%
2006 -S$0.04 Million-79.99%
2005 -S$0.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
S$86.03 M-242.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$8.53 Million-85.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
S$84.46 M-240.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-S$6.18 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA